Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Misty Shields

Thoracic Oncology · IUSM

View

Dr. Gilberto Lopes

Thoracic Oncology · University of Miami

View

Dr. Jacob Sands

Thoracic Oncology · Dana-Farber Cancer Institute

View

Dr. Kathleen Cooney

GU Oncology · Duke

View

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Julia Close

General Oncology · UF

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Allison Fitzgerald

General Oncology · Dana-Farber Cancer Institute

View

Dr. Jason Mouabbi

Breast Oncology · MD Anderson Cancer Center

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    MRDr. Meera Ragavan

    Dr. Meera Ragavan

    Medical Oncology · Thoracic Oncology
    Kaiser Permanente San Francisco Medical Center
    meera

    Research

    High-Deductible Health Plans and Mortality Among Cancer Survivors

    2026

    Via JAMA Network Open

    Research

    Band-Aids Can Still Help Heal: The Role of Patient Financial Assistance Programs in Addressing Financial Toxicity

    2025

    Via JCO Oncology Practice

    Research

    Screening for Comprehensive Social Needs in Patients with Cancer: A Narrative Review

    2025

    Via JNCI Cancer Spectrum

    Research

    The Role of Targetable Biomarker Alterations in Overall Survival for Non-Small Cell Lung Cancer (NSCLC) in a Large Integrated Health System

    2025

    Via Journal of Thoracic Disease

    Research

    Access to Financial Assistance Programs and Their Impact on Overall Spending on Oral Anticancer Medications at an Integrated Specialty Pharmacy

    2024

    Via JCO Oncology Practice

    Research

    Lay Healthcare Worker Financial Toxicity Intervention: A Pilot Financial Toxicity Screening and Referral Program

    2024

    Via Supportive Care in Cancer

    Research

    Pharmacy Assistance Programs for Oral Anticancer Drugs: A Narrative Review

    2024

    Via JCO Oncology Practice

    Research

    Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study

    2024

    Via Journal of Thoracic Oncology

    Research

    Receipt of Financial Assistance for Oral Targeted Therapy Among Older Adults with Advanced Non-Small Cell Lung Cancer: A Prospective Cohort Study

    2024

    Via Journal of Geriatric Oncology

    Research

    Beyond the PSA: The Hidden Costs of Screening in Prostate Cancer

    2024

    Via Cancer

    Research

    Clinical Validity and Utility of Circulating Tumor DNA (ctDNA) Testing in Advanced Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review and Meta-Analysis

    2024

    Via Molecular Diagnosis & Therapy

    Research

    Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC

    2024

    Via Journal of Thoracic Oncology

    Research

    Private Payer and Medicare Coverage Policies for Use of Circulating Tumor DNA Tests in Cancer Diagnostics and Treatment

    2023

    Via Journal of the National Comprehensive Cancer Network

    Research

    The Costs and Inequities of Precision Medicine for Patients with Prostate Cancer: A Call to Action

    2023

    Via Urologic Oncology

    Research

    The Health Inequality Impact of Liquid Biopsy to Inform First-Line Treatment of Advanced Non-Small Cell Lung Cancer: A Distributional Cost-Effectiveness Analysis

    2023

    Via Value in Health